Chronic diseases spectrum and multimorbidity in elderly inpatients based on a 12-year epidemiological survey in China

Shan Gao,Shasha Sun,Ting Sun,Tingting Lu,Yan Ma,Hebin Che,Miao Liu,Wanguo Xue,Kunlun He,Yabin Wang,Feng Cao
DOI: https://doi.org/10.1186/s12889-024-18006-x
IF: 4.5
2024-02-20
BMC Public Health
Abstract:The number and proportion of the elderly population have been continuously increasing in China, leading to the elevated prevalence of chronic diseases and multimorbidity, which ultimately brings heavy burden to society and families. Meanwhile, the status of multimorbidity tends to be more complex in elderly inpatients than community population. In view of the above concerns, this study was designed to investigate the health status of elderly inpatients by analyzing clinical data in Chinese People's Liberation Army (PLA) General Hospital from 2008 to 2019, including the constitution of common diseases, comorbidities, the status of multimorbidity, in-hospital death and polypharmacy among elderly inpatients, so as to better understand the diseases spectrum and multimorbidity of elderly inpatients and also to provide supporting evidence for targeted management of chronic diseases in the elderly.
public, environmental & occupational health
What problem does this paper attempt to address?
The paper aims to study the disease spectrum, comorbidity, and polypharmacy status of elderly inpatients aged 65 and above at the Chinese PLA General Hospital from 2008 to 2019, in order to better understand the disease spectrum and multiple comorbidities of elderly inpatients and provide supporting evidence for targeted management of chronic diseases in the elderly. Through a retrospective analysis of the elderly inpatient data from the PLA General Hospital, the paper found that malignant tumors, hypertension, ischemic heart disease, diabetes, and cerebrovascular diseases are the five most common diseases. Additionally, the study showed that 91.89% of elderly inpatients have two or more long-term health problems, with an average of 4.68 diseases per patient. Multiple comorbidities severely impact the process of healthy aging and increase the burden on families and society. Therefore, it is necessary to strengthen multidisciplinary treatment and develop reasonable prevention and treatment strategies to improve the quality of life for the elderly. At the same time, more attention should be paid to rational medication for elderly patients with multiple comorbidities to avoid preventable side effects caused by inappropriate drug treatments.